656:HKEXFosun International Limited Analysis
Data as of 2026-07-27 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
iMD (656) is trading around TWD 28, just below its 20‑day SMA (~28) and further under its 50‑day (~28.6) and 200‑day (~29.2) averages, confirming a bearish price bias. The RSI sits near the mid‑range at 48, while the MACD line has turned positive (0.04) against a negative signal line, suggesting a tentative short‑term bullish swing but without decisive momentum. Volume is increasing, yet the stock exhibits extreme 30‑day volatility (≈45%) and a negative beta, highlighting heightened price swings independent of the market. Fundamentally, the company reports declining revenue, negative operating and net margins, and substantial cash‑flow deficits, with a high price‑to‑book multiple (≈2.9) despite no earnings. The balance sheet shows modest leverage (debt‑to‑equity ~30%) but limited cash relative to ongoing cash‑burn. In an environment of extreme market greed (fear‑greed index 88), the technical softness and weak fundamentals make the current price appear stretched.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below all major moving averages indicating bearish trend
- High short‑term volatility and negative beta amplifying price risk
- Negative earnings, margins and cash flow undermine upside potential
Medium Term
1–3 yearsKey Factors
- MACD histogram turning positive suggests a possible technical bounce
- Rising volume may support a modest recovery
- Fundamental weaknesses (losses, cash‑flow deficit) remain unresolved
Long Term
> 3 yearsKey Factors
- Sustained operating losses and negative ROE signal structural challenges
- Debt level relative to equity and limited cash cushion increase financial risk
- Cyclical semiconductor market and geopolitical exposure in Taiwan add uncertainty
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.